Priority Date: 12.12.11 (US 201161569604P)

COMPOSITION AND METHOD FOR TREATING NUCLEIC ACID-RELATED EYE DISEASE

  • Application ID: EP12858050
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 2009
Headquarter in Lyngby and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Guardian IP Consulting I/S is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 12.12.2011 - Priority Date (US 201161569604P)
  • 20.06.2013 - Publication A1 (WO2013089835)
  • 22.10.2014 - Publication A1 (EP2790722)